Abstract
Background
Prostacyclin is a potent vasodilator, inhibitor of leukocyte adhesion, and platelet aggregation, and has been suggested as therapy for cerebral ischemia. A case of focal traumatic brain lesion that was monitored using intracerebral microdialysis, and bedside analysis and display is reported here. When biochemical signs of cerebral ischemia progressed, i.v. infusion of prostacyclin was started.
Methods
Two microdialysis catheters were placed in the penumbra zones surrounding evacuated focal brain contusions. The samples were analyzed for glucose, pyruvate, lactate, glutamate, and glycerol.
Results
When biochemical deterioration indicated progressive secondary ischemia (increase in lactate/pyruvate ratio, decrease in glucose, and increase in glutamate levels), continuous infusion of prostacyclin (0.5–1.0 ng kg−1 min−1 i.v.) was started. The treatment resulted in an improvement of the lactate/pyruvate ratios and a normalization of the interstitial levels of glucose and glutamate. The glycerol levels remained within normal limits indicating that degradation of cellular membranes had not occurred.
Conclusion
The above case supports the view that new therapies directed toward protection of the sensitive biochemical penumbra zones surrounding focal brain lesions may be evaluated by intracerebral microdialysis.
Similar content being viewed by others
References
Engström M, Polito A, Reinstrup P, et al. Intracerebral microdialysis in severe brain trauma—the importance of catheter location. J Neurosurg. 2005;102:460–9.
Nordström CH. Assessment of critical thresholds for cerebral perfusion pressure by bedside monitoring of regional energy metabolism. Neurosurg Focus. 2003;15(6):1–8. Article 5.
Nordström CH, Reinstrup P, Xu W, Gärdenfors A, Ungerstedt U. Assessment of the lower limit for cerebral perfusion pressure in severe head injuries by bedside monitoring of regional energy metabolism. Anesthesiology. 2003;98:809–14.
Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet. 1974;2(7872):81–4.
Nordström CH. Treatment of increased intracranial pressure: physiological and biochemical principles underlying volume targeted therapy—the “Lund concept”. Neurocrit Care. 2005;2:83–96.
Reinstrup P, Ståhl N, Mellergård P, Uski T, Ungerstedt U, Nordström CH. Intracerebral microdialysis in clinical practice. Normal values and variations during anaesthesia and neurosurgical operations. Neurosurgery. 2000;47:701–10.
Bath PMW. Prostacyclin and analogues for acute ischaemic stroke. Cochrane Database Syst Rev. 2004;3:CD000177.
Moncada S. Biology and therapeutic potential of postacyclin. Stroke. 1983;14:157–68.
Moncada S, Gryglewski R, Bunting S, Vane JR. An enzyme isolated from arteries transform prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature. 1976;263:663–5.
Brandt L, Ljunggren B, Andersson KE, Hindfelt B, Uski T. Effects of indomethacin and prostacyclin on isolated human pial arteries contracted by CSF from patients with aneurysmal SAH. J Neurosurg. 1981;55:877–83.
Koskinen LO, Olivecrona M, Rodling-Wahlström M, Naredi S. Prostacyclin treatment normalises the MCA flow velocity in nimodipine-resistant cerebral vasospasm after aneurismal subarachnoid haemorrhage. Acta Neurochir. 2009;151:595–9.
Gryglewski RJ, Nowak S, Kostka-Trabka E, et al. Treatment of ischaemic stroke with prostacyclin. Stroke. 1983;14:197–202.
Bentzer P, Mattiason G, McIntosh T, Wieloch T, Grände PO. Infusion of prostacyclin following experimental brain injury in the rat reduces cortical lesion volume. J Neurotrauma. 2001;18:275–85.
Bentzer P, Venturoli D, Carlsson O, Grände PO. Low-dose prostacyclin improves cortical perfusion following experimental brain injury in the rat. J Neurotrauma. 2003;20:447–61.
Grände PO, Möller AD, Nordström CH, Ungerstedt U. Low-dose prostacyclin in treatment of severe brain trauma evaluated with microdialysis and jugular bulb oxygen measurements. Acta Anaesthesiol Scand. 2000;44:886–94.
Naredi S, Olivecrona M, Lindgren C, Ostlund AL, Grände PO. KoskinenLO. An outcome study o severe traumatic head injury using the “Lund therapy” with low-dose prostacyclin. Acta Anaesthesiol Scand. 2001;45:402–6.
Gärdenfors A, Nilsson F, Skagerberg G, Ungerstedt U, Nordström CH. Adverse biochemical and physiological effects of prostacyclin in experimental brain edema. Acta Anaesthesiol Scand. 2004;48:1316–21.
Ståhl N, Mellergård P, Hallström Å, Ungerstedt U, Nordström CH. Intracerebral microdialysis and bedside biochemical analysis in patients with fatal traumatic brain lesions. Acta Anaesthesiol Scand. 2001;45:977–85.
Jorgensen MB, Diemer NH. Selective neuronal loss after cerebral ischemia in the rat: possible role of transmitter glutamate. Acta Neurol Scand. 1982;66:536–46.
Rothman SM. Synaptic activity mediates death of hypoxic neurons. Science. 1983;220:536–7.
Samuelsson C, Hillered L, Zetterling M, et al. Cerebral glutamine and glutamate levels in relation to compromised energy metabolism: a microdialysis study in subarachnoid hemorrhage patients. J Cereb Blood Flow Metab. 2007;27:1309–17.
Hillered L, Valtysson J, Enblad P. PerssonL. Interstitial glycerol as a marker for membrane phospholipid degradation in the acutely injured human brain. J Neurol Neurosurg Psychiatry. 1998;64:486–91.
Nordström C-H. Ungerstedt U: intracerebral microdialysis with bedside analysis of lactate, glucose, glycerol and urea. In: Diemath HE, editor. Brain protection in severe head injury. München: W Zuckswerdt Verlag; 1996. p. 117–9.
Olivecrona M, Rodling-Wahlström M, Naredi S, Koskinen LO. Prostacyclin treatment in severe traumatic brain injury: a microdialysis and outcome study. J Neurotrauma. 2009;26:1251–62.
Acknowledgments
The study was supported by grants from the Swedish Medical Research Council (14X-003574-28D), and Lund University Hospital. We thank Katarina Nielsen, Department of Neurosurgery, Lund University Hospital, for her help with the microdialysis equipment and biochemical analyses.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Reinstrup, P., Nordström, CH. Prostacyclin Infusion May Prevent Secondary Damage in Pericontusional Brain Tissue. Neurocrit Care 14, 441–446 (2011). https://doi.org/10.1007/s12028-010-9486-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12028-010-9486-3